cancer immunotherapy

KEI Comments on Exclusive License to Stage One Immunotherapeutics

Posted on by Claire Cassedy

On October 20, 2025, Knowledge Ecology International (KEI) submitted comments to the NIH in response to the Federal Register notice titled, “Prospective Grant of an Exclusive Patent License: Substituted Quinoline Analogs As Aldehyde Dehydrogenase 1A1 Inhibitors” (90 FR 47782) The… Continue Reading →

KEI Requests the NIH to Investigate Failure to Disclose Federal Funding in Opdivo and Keytruda Patents

Posted on by Claire Cassedy

On December 20, 2019, Knowledge Ecology International (KEI) filed a request to the National Institutes of Health (NIH) that it investigate an apparent failure to disclose federal funding in patents associated with cancer immunotherapies Opdivo and Keytruda. A court case… Continue Reading →